Mild side-effects have been reported after use of all three vaccines, the AIFA report said, adding most involved flu-like symptoms, pain in the injection site and tiredness. Like many European countries, Italy briefly halted AstraZeneca inoculations last month when blood clot concerns surfaced. It has since resumed them for those aged 60 and above after EU regulators said the benefits outweighed the risks. AIFA said there had been 11 cases in Italy of people developing one of two types of blood clots following their AstraZeneca shot - cerebral venous sinus thrombosis (CVST) and thrombosis involving multiple blood vessels. AstraZeneca has said it is "working to understand individual cases and "possible mechanisms that could explain these extremely rare events".

Source: bd News24 April 15, 2021 15:00 UTC